Cost-effectiveness of cyclooxygenase-2 inhibitors in chronic arthritis.
Pellissier
James M
JM
Watson
Douglas J
DJ
Kong
Sheldon X
SX
Straus
Walter L
WL
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000191:economics*; D006801:Humans; D007527:Isoenzymes / Q000191:economics*; D008565:Membrane Proteins; D010003:Osteoarthritis / Q000188:drug therapy*; D011451:Prostaglandin-Endoperoxide Synthases / Q000191:economics*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases